An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

OʼReilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,344

Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry

Maniotis, A. J., Folberg, R., Hess, A. R., Seftor, E. A., Gardner, L. M. G., Pe’er, J., Trent, J. M., Meltzer, P. S., & Hendrix, M. J. C. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65173-5 · Cited by 2,049

The pathogenesis of cancer metastasis

Poste, G. H., & Fidler, I. J. (1980) · Nature · doi:10.1038/283139a0 · Cited by 1,739

Tumor angiogenesis: past, present and the near future

Kerbel, R. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.505 · Cited by 985

Bone matrix RGD glycoproteins: Immunolocalization and interaction with human primary osteoblastic bone cells in vitro

Grzesik, W. J., & Robey, P. G. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090408 · Cited by 369

The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.

Ferracini, R., Renzo, M. F. D., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P., Cremona, O., Campanacci, M., & Comoglio, P. M. (1995) · PubMed · Cited by 280

Modulation of the Organ Microenvironment for Treatment of Cancer Metastasis

Fidler, I. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.21.1588 · Cited by 240

Comparative Aspects of Osteosarcoma

Withrow, S. J., Powers, B. E., Straw, R. C., & Wilkins, R. M. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199109000-00023 · Cited by 239

Angiogenesis Inhibitors Generated by Tumors

Folkman, J. (1995) · Molecular Medicine · doi:10.1007/bf03401559 · Cited by 219

Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma

Mochizuki, Y., Tazawa, H., Demiya, K., Kure, M., Kondo, H., Komatsubara, T., Sugiu, K., Hasei, J., Yoshida, A., Kunisada, T., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02774-7 · Cited by 30

Apoptosis Resistance and PKC Signaling: Distinguishing Features of High and Low Metastatic Cells

Hong, S.-H., Ren, L., Mendoza, A., Eleswarapu, A. S., & Khanna, C. (2012) · Neoplasia · doi:10.1593/neo.111498 · Cited by 28

Animal models for studying lung cancer and evaluating novel intervention strategies

Liu, J., & Johnston, M. R. (2002) · Surgical Oncology · doi:10.1016/s0960-7404(02)00053-1 · Cited by 29

mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo

Morrow, J. J., Mendoza, A., Koyen, A., Lizardo, M. M., Ren, L., Waybright, T. J., Hansen, R. J., Gustafson, D. L., Zhou, M., Fan, T. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0326 · Cited by 27

Plumbagin exhibits an anti-proliferative effect in human osteosarcoma cells by downregulating FHL2 and interfering with Wnt/β-catenin signalling

Xue, Y.-L., Meng, X., Ma, L.-J., & Yuan, Z. (2016) · Oncology Letters · doi:10.3892/ol.2016.4725 · Cited by 27

Animal models of osteosarcoma

Fan, T. M. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.107 · Cited by 28

Biological characterization of preclinical Bioluminescent Osteosarcoma Orthotopic Mouse (BOOM) model: A multi-modality approach

Garimella, R., Eskew, J. D., Bhamidi, P., Vielhauer, G. A., Hong, Y., Anderson, H. C., Tawfik, O. W., & Rowe, P. S. (2013) · Journal of bone oncology · doi:10.1016/j.jbo.2012.12.005 · Cited by 26

Highly metastatic K7M2 cell line: A novel murine model capable of in vivo imaging via luciferase vector transfection

Grisez, B. T., Ray, J. J., Bostian, P. A., Markel, J., & Lindsey, B. A. (2018) · Journal of Orthopaedic Research® · doi:10.1002/jor.23868 · Cited by 25

Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis

Sévère, N., Dieudonné, F., Marty, C., Modrowski, D., Patiño‐García, A., Lecanda, F., Fromigué, O., & Marie, P. J. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1667 · Cited by 26

Targeted Therapies in Bone Sarcomas

Scotlandi, K., Picci, P., & Kovar, H. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909789760410 · Cited by 26

Metastatic Osteosarcoma Gene Expression Differs In Vitro and In Vivo

Lisle, J. W., Choi, J. Y., Horton, J. A., Allen, M. J., & Damron, T. A. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0309-1 · Cited by 27

Pulmonary metastasetomy for osteosarcoma: is it justified?

Diemel, K., Klippe, H. J., & Branseheid, D. (2009) · PubMed · Cited by 24

An orthotopic, postsurgical model of luciferase transfected murine osteosarcoma with spontaneous metastasis

Sottnik, J. L., Duval, D. L., Ehrhart, E. J., & Thamm, D. H. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9318-z · Cited by 24

ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2

Kumar, R. M. R., Betz, M., Robl, B., Born, W., & Fuchs, B. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-559 · Cited by 25

Bone sarcomas: pathogenesis and new therapeutic approaches

Heymann, D., & Rédiní, F. (2011) · IBMS BoneKEy · doi:10.1138/20110531 · Cited by 26

Effects of Different Electroacupuncture Scheduling Regimens on Murine Bone Tumor-Induced Hyperalgesia: Sex Differences and Role of Inflammation

Smeester, B. A., Al-Gizawiy, M. M., & Beitz, A. J. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/671386 · Cited by 23

SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis

Smeester, B. A., Slipek, N. J., Pomeroy, E. J., Bomberger, H. E., Shamsan, G. A., Peterson, J. J., Crosby, M. R., Draper, G. M., Becklin, K. L., Rahrmann, E. P., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1041-x · Cited by 21

Bempegaldesleukin ( BEMPEG ; NKTR ‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcoma

Hennessy, M., Wahba, A., Felix, K., Cabrera, M., Segura, M. G., Kundra, V., Ravoori, M. K., Stewart, J., Kleinerman, E. S., Jensen, V. B., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33382 · Cited by 21

The Effect of Electroacupuncture on Osteosarcoma Tumor Growth and Metastasis: Analysis of Different Treatment Regimens

Smeester, B. A., Al-Gizawiy, M. M., O’Brien, E. E., Ericson, M. E., Triemstra, J. L., & Beitz, A. J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/387169 · Cited by 22

Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines

Collier, C. D., Wirtz, E. C., Knafler, G. J., Morris, W. Z., Getty, P. J., & Greenfield, E. M. (2018) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999.0000000000000059 · Cited by 22

The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

Hebron, K. E., Wan, X., Roth, J. S., Liewehr, D. J., Sealover, N. E., Frye, W. J. E., Kim, A., Stauffer, S., Perkins, O. L., Sun, W., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1646 · Cited by 19

Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model

Schiller, K. R., Zillhardt, M., Alley, J. F., Borjesson, D. L., Beitz, A. J., & Mauro, L. J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-45 · Cited by 20

The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteosarcoma mouse models and exhibits severe liver toxicity

Arlt, M., Walters, D. K., Banke, I. G. J., Steinmann, P., Puskás, G. J., Bertz, J., Rentsch, K., Ehrensperger, F., Born, W., & Fuchs, B. (2011) · International Journal of Cancer · doi:10.1002/ijc.27378 · Cited by 19

Combination Therapy with Disulfiram, Copper, and Doxorubicin for Osteosarcoma: In Vitro Support for a Novel Drug Repurposing Strategy

Mandell, J. B., Lu, F., Fisch, M., Beumer, J. H., Guo, J., Watters, R. J., & Weiss, K. R. (2019) · Sarcoma · doi:10.1155/2019/1320201 · Cited by 18

Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma

Kowalczyk, J. T., Wan, X., Hernandez, E. R., Luo, R., Lyons, G. C., Wilson, K. M., Gallardo, D. C., Isanogle, K. A., Robinson, C. M., Mendoza, A., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0525 · Cited by 18

Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin‐like growth factor I

Hong, S., Briggs, J., Newman, R. J., Hoffman, K. E., Mendoza, A., LeRoith, D., Helman, L. J., Yakar, S., & Khanna, C. (2008) · International Journal of Cancer · doi:10.1002/ijc.24169 · Cited by 18

ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo

Jullien, N. D., Dieudonné, F., Habel, N., Marty, C., Modrowski, D., Patiño‐García, A., Lecanda, F., Sévère, N., & Marie, P. J. (2013) · Gene · doi:10.1016/j.gene.2013.03.031 · Cited by 17

Non-invasive imaging correlates with histological and molecular characteristics of an osteosarcoma model: application for early detection and follow-up of MDR phenotype.

Dutour, A., Leclers, D., Monteil, J., Paraf, F., Charissoux, J.-L., Rousseau, R. F., & Rigaud, M. (2007) · PubMed · Cited by 17

Chick Embryo Extract Demethylates Tumor Suppressor Genes in Osteosarcoma Cells

Mu, X., Sultankulov, B., Agarwal, R., Mahjoub, A., Schott, T., Greco, N., Huard, J., & Weiss, K. R. (2013) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-013-3104-6 · Cited by 17

Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice

Jaroensong, T., Endo, Y., Lee, S. ‐., Kamida, A., Mochizuki, M., Nishimura, R., Sasaki, N., & Nakagawa, T. (2011) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2011.00294.x · Cited by 16

Quantifying intra‐osseous growth of osteosarcoma in a murine model with radiographic analysis

Cole, H., Ichikawa, J., Colvin, D. C., O’Rear, L., & Schoenecker, J. G. (2011) · Journal of Orthopaedic Research® · doi:10.1002/jor.21474 · Cited by 16

Disulfiram reduces metastatic osteosarcoma tumor burden in an immunocompetent Balb/c or-thotopic mouse model

Crasto, J. A., Fourman, M. S., Morales-Restrepo, A., Mahjoub, A., Mandell, J. B., Ramnath, K., Tebbets, J. C., Watters, R. J., & Weiss, K. R. (2018) · Oncotarget · doi:10.18632/oncotarget.25733 · Cited by 17

Engineered bone marrow as a clinically relevant ex vivo model for primary bone cancer research and drug screening

Griffin, K. H., Thorpe, S. W., Sebastian, A., Hum, N. R., Coonan, T. P., Sagheb, I. S., Loots, G. G., Randall, R. L., & Leach, J. K. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302101120 · Cited by 15

Interleukin-11 receptor α is overexpressed in human osteosarcoma, and near-infrared-labeled IL-11Rα imaging agent could detect osteosarcoma in mouse tumor xenografts

Liu, T., Ma, Q., Zhang, Y., Shi, K., Yan, K., Chen, X. '., Wen, Y., Fan, Q., & Qiu, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-2844-6 · Cited by 15

Impact of limb amputation and cisplatin chemotherapy on metastatic progression in mouse models of osteosarcoma

Ren, L., Huang, S., Beck, J. A., & LeBlanc, A. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-04018-9 · Cited by 13

Metastatic Hepatocarcinoma He/De Tumor Model in Rat

Trencsényi, G., Márián, T., Bako, F., Emri, M., Nagy, G., Kertai, P., & Bánfalvi, G. (2014) · Journal of Cancer · doi:10.7150/jca.9315 · Cited by 13

Evaluation of F8-TNF-α in Models of Early and Progressive Metastatic Osteosarcoma

Robl, B., Botter, S. M., Boro, A., Meier, D., Neri, D., & Fuchs, B. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.02.005 · Cited by 13

IRF5 suppresses metastasis through the regulation of tumor-derived extracellular vesicles and pre-metastatic niche formation

Roberts, B. K., Li, D. I., Somerville, C. C., Matta, B., Jha, V. J., Steinke, A. M., Brune, Z., Blanc, L., Soffer, S. Z., & Barnes, B. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-66168-w · Cited by 15

A novel noninvasive method for evaluating experimental lung metastasis in mice.

Mendoza, A., Gharpure, R. V., Dennis, J. U., Webster, J. D., Smedley, J. V., & Khanna, C. (2013) · Europe PMC (PubMed Central) · Cited by 12

Establishment and characterization of a new highly metastatic human osteosarcoma cell line derived from Saos2.

Du, L., Fan, Q., Tu, B., Yan, W., & Tang, T. (2014) · PubMed Central · Cited by 11

The Role of ALDH in the Metastatic Potential of Osteosarcoma Cells and Potential ALDH Targets

Belayneh, R., & Weiss, K. R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_10 · Cited by 11

Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma

Zalacaín, M., Buñuales, M., Marrodán, L., Labiano, S., González-Huarriz, M., Martínez-Vélez, N., Laspidea, V., Puigdelloses, M., García-Moure, M., González-Aparicio, M., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.11.003 · Cited by 9

B7-H3 protein expression in a murine model of osteosarcoma

ZHAO, J.-L., Chen, F., Zhou, Q., Pan, W. X., WANG, X.-H., Xu, J. Y., ZHANG, S.-X., Li, N., & Yang, H. (2016) · Oncology Letters · doi:10.3892/ol.2016.4675 · Cited by 10

Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis

Cates, J., Friedman, D. B., Seeley, E. H., Dupont, W. D., Schwartz, H. S., Holt, G. E., Caprioli, R. M., & Young, P. P. (2010) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2010.00711.x · Cited by 10

Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model

Sorenson, B. S. (2010) · Biologics · doi:10.2147/btt.s9121 · Cited by 10

Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma

Ringwalt, E. M., Currier, M. A., Glaspell, A. M., Chen, C., Cannon, M. V., Cam, M., Gross, A. C., Gust, M. J., Wang, P.-Y., Boon, L., et al. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200886 · Cited by 9

Mammalian models of bone sarcomas

Botter, S. M., Arlt, M., Born, W., & Fuchs, B. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416721-6.00030-3 · Cited by 10

Histopathology and Molecular Pathology of Bone and Extraskeletal Osteosarcomas

Trihia, H., & Valavanis, C. (2012) · InTech eBooks · doi:10.5772/31431 · Cited by 9

Osteosarcoma

Tattersall, L., Davison, Z., & Gartland, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62259-6 · Cited by 10

Osteosarcoma-Induced Pain Is Mediated by Glial Cell Activation in the Spinal Dorsal Horn, but Not Capsaicin-Sensitive Nociceptive Neurons: A Complex Functional and Morphological Characterization in Mice

Bencze, N., Scheich, B., Szőke, É., Wilhelm, I., Körmöndi, S., Botz, B., & Helyes, Z. (2024) · Cancers · doi:10.3390/cancers16101788 · Cited by 8

Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide

Byrgazov, K., Anderson, C. N., Salzer, B., Bozsaky, E., Larsson, R. L., Gullbo, J., Lehner, M., Lehmann, F., Slipicevic, A., Kager, L., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920937891 · Cited by 8

Multimodal Mass Spectrometry Imaging of an Osteosarcoma Multicellular Tumour Spheroid Model to Investigate Drug-Induced Response

Pearce, S. M., Cross, N. A., Smith, D. P., Clench, M. R., Flint, L., Hamm, G. R., Goodwin, R. J. A., Langridge, J., Claude, E., & Cole, L. M. (2024) · Metabolites · doi:10.3390/metabo14060315 · Cited by 7

Targetable Intercellular Signaling Pathways Facilitate Lung Colonization in Osteosarcoma

Reinecke, J. B., & Roberts, R. D. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_7 · Cited by 7

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Ishiyama, S., Kissel, C. L., Guo, X., Howard, A., Saeki, H., Ito, T., Sysa‐Shah, P., Orita, H., Sakamoto, K., & Gabrielson, K. L. (2021) · Journal of Visualized Experiments · doi:10.3791/62139 · Cited by 6

Osteosarcoma

Janeway, K. A., Gorlick, R. G., & Bernstein, M. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3431-5.00022-4 · Cited by 6

Extracellular matrix production and oxygen diffusion regulate chemotherapeutic response in osteosarcoma spheroids

Sagheb, I. S., Coonan, T. P., Randall, R. L., Griffin, K. H., & Leach, J. K. (2024) · Cancer Medicine · doi:10.1002/cam4.70239 · Cited by 5

LIPA-driven reprogramming of tumor-associated macrophages shapes an immunosuppressive microenvironment in osteosarcoma

Guo, Z., Zou, Y., Liao, Y., Chen, J., Chen, W., Tu, J., Wen, L. Q., Yao, H., & Xie, X. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116110 · Cited by 5

Dual CDK4/6–PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcoma

Barghi, F., Saadatzadeh, M. R., Dobrota, E. A., Shannon, H. E., Bailey, B. J., Young, C., Malko, R., Justice, R. E., Riyahi, N., Davis, C. M., et al. (2026) · Neoplasia · doi:10.1016/j.neo.2025.101266 · Cited by 6

Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts

Fischer, S., Creytens, D., Geyter, S. D., Vlieghere, E. D., Pattyn, P., Bekaert, S.-L., Durinck, K., Roy, N. V., Hendrix, A., Lapeire, L., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1290 · Cited by 5

Establishment and cytogenetic characterization of a cell line from a pulmonary metastasis of osteosarcoma

Salinas-Souza, C., Oliveira, I. D., de Oliveira, R., Alves, M. T. D. S., Petrilli, A. S., & de Toledo, S. R. C. (2012) · Cytotechnology · doi:10.1007/s10616-012-9487-5 · Cited by 5

Identification of potential modulators of osteosarcoma metastasis by high‐throughput cellular screening of natural products

Long, S. A., Huang, S., Kambala, A., Ren, L., Wilson, J. A., GOETZ, M. A., Hao, X., Yang, X., Goncharova, E. I., Jia, L., et al. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13762 · Cited by 5

Macrophage and osteosarcoma cell crosstalk is dependent on oxygen tension and 3D culture

Griffin, K. H., Sagheb, I. S., Coonan, T. P., Fierro, F. A., Randall, R. L., & Leach, J. K. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.214154 · Cited by 4

Exploring the Role of Neutrophil-Related Genes in Osteosarcoma via an Integrative Analysis of Single-Cell and Bulk Transcriptome

Lu, J., Jiang, R., Xu, X., & Shen, J. (2024) · Biomedicines · doi:10.3390/biomedicines12071513 · Cited by 4

Gene and Virotherapy Against Osteosarcoma

Ketola, A. (2009) · Cited by 4

An improved experimental model of osteosarcoma lung metastases to investigate innovative therapeutic interventions and sex as a biological variable

Sunbul, F. S., Almuqbil, R. M., Zhang, H., Alhudaithi, S. S., Fernandez, M. E., Aldaqqa, R. R., Garcia, V. A., Robila, V., Halquist, M. S., Gordon, S. W., et al. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125372 · Cited by 3

Murine and Canine Models of Appendicular Osteosarcoma

Fan, T. M. (2007) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1401s37 · Cited by 3

Osteosarcoma: mouse models, cell of origin and cancer stem cell

Guijarro, M. V. (2014) · Postdoc Journal · doi:10.14304/surya.jpr.v2n2.3 · Cited by 3

Reverse micelles produce hydroxyapatite nanoparticles as more efficient gene delivery carriers than regular micelles

Uskoković, V. (2026) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2026.184506 · Cited by 2

Generation of post-surgical minimal residual disease models to investigate metastasis in soft tissue sarcoma patient-derived orthotopic xenografts

Fischer, S., Creytens, D., Gijsels, S., Descamps, B., Lapeire, L., Hendrix, A., Sys, G. M. L., & Wever, O. D. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.102863 · Cited by 2

Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma

Gill, K. S., Fernandes, P., Bird, B., Soden, D. M., & Forde, P. F. (2018) · Oncotarget · doi:10.18632/oncotarget.25843 · Cited by 2

STING activation reshapes the tumor microenvironment leading to tumor regression in osteosarcomaPreprint

Young, E. P., Johnson, C. A., Lee, A. G., Morris, D., Tsui, J. L., Breese, M. R., Cámara, J. A., Schott, C. R., Abram, C. L., Leung, S. G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.24.684275 · Cited by 2

Establishing Human and Canine Xenograft Murine Osteosarcoma Models for Application of Focused Ultrasound Ablation

Hay, A. N., Simon, A., Ruger, L. N., Gannon, J., Coutermarsh‐Ott, S. L., Vickers, E., Eward, W. C., Neufeld, N. J., Vlaisavljevich, E., & Tuohy, J. L. (2025) · Biomedicines · doi:10.3390/biomedicines13092122 · Cited by 1

Stiffness-transformable photoimmune nanostimulators for remodeling tumor microenvironment of osteosarcoma and inhibiting lung metastasis

Yi, X., Tao, J., Chen, Y., Yuan, Y., Teng, Z., Li, P., & Yu, A. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.168995 · Cited by 1

Quantitative detection of macrophage activation in osteosarcoma comparing 18F-FDG PET/CT with ferumoxytol-enhanced MRI

Roudi, R., Habte, F. G., Saladino, G. M., Vasyliv, I., Pisani, L. J., Wong, J., Syed, A., & Daldrup-Link, H. E. (2026) · Scientific Reports · doi:10.1038/s41598-026-56539-w · Cited by 1

Nanostructured selenium anti-cancer coatings for orthopedic applications

Tran, P. A., & Webster, T. J. (2012) · Elsevier eBooks · doi:10.1533/9780857096449.2.180 · Cited by 1

Modeling osteosarcoma: in vitro and in vivo approaches

Walkley, C. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416721-6.00017-0 · Cited by 2

Animal Models of Malignant Primary Bone Tumors and Novel Therapeutic Approaches

Rousseau, J., Lamoureux, F., Picarda, G. G. A., Gouin, F., Trichet, V., & Rédiní, F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374895-9.00028-1 · Cited by 2

Repurposing riluzole as an anti-osteosarcoma agent

Jung, O., Rajasekhar, V. K., Azeem, S. M., ChandThakuri, S., Norton, B., Healey, J. H., & Mahajan, S. S. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1508819 · Cited by 1

Molecularly Targeted Therapy for Osteosarcoma: Where Do We Go from Here?

Ricafort, R. J., & Gorlick, R. G. (2010) · Springer eBooks · doi:10.1007/978-0-387-69062-9_21 · Cited by 1

Transition between canonical to non-canonical Wnt signaling during interactions between mesenchymal stem cells and osteosarcomas

Masha, A., Ben, G.-P. N., Cohen, E. I., Yvonne, V., & Vago, R. (2020) · Open Journal of Orthopedics and Rheumatology · doi:10.17352/ojor.000025 · Cited by 1

Drug Discovery in Pediatric Bone and Soft Tissue Sarcomas Using In Vivo Models

Peterson, J. K., & Houghton, P. J. (2005) · Springer eBooks · doi:10.1007/3-540-29447-3_5 · Cited by 1

Molecular and cellular mechanisms of osteosarcoma metastasis: current knowledge and perspectives

Fuchs, B., & Born, W. (2009) · Current Orthopaedic Practice · doi:10.1097/bco.0b013e3181ae67c2 · Cited by 1

Estudo da associação das variáveis clínico-patológicas com a expressão imunoistoquímica de Ezrin e CD44 em pacientes portadores de osteossarcoma

Boldrini, É. (2010) · doi:10.11606/d.5.2010.tde-27052010-161534 · Cited by 1

Positively Selected Enhancer Elements Endow Tumor Cells with Metastatic CompetencePreprint

Morrow, J. J., Bayles, I., Funnell, A. P. W., Miller, T. E., Saiakhova, A., Lizardo, M. M., Bartels, C. F., Kapteijn, M. Y., Hung, S., Mendoza, A., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/155416 · Cited by 1

Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma SpheroidsPreprint

Seiden, E. E., Richardson, S. M., Everitt, L. A., Knafler, G. J., Kinsella, G. P., Walker, A. L., Whiteside, V. A., Buschbach, J. D., Gandhi, D. A., Saadatzadeh, M. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.22.654354 · Cited by 1

Haematogenous Models of Metastases

Logan, P. T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3685-0_15

Effects of electroacupuncture in a mouse model of experimentally-induced osteosarcoma.

Al-Gizawiy, M. M. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)

Hematopoietic Cell Transplantation for Other Pediatric Solid Tumors

Loeb, D. M., & Chen, A. R. (2009) · doi:10.1002/9781444303537.ch67

Obtenção e caracterização de linhagem celular primária de osteossarcoma canino

Alcântara, D. (2010) · doi:10.11606/d.10.2010.tde-01042011-154719

Laboratory Models of Lung Cancer

Liu, J., & Johnston, M. R. (2006) · Springer eBooks · doi:10.1007/3-540-31040-1_4

CORR Insights®: Do Mesenchymal Stromal Cells Influence Microscopic Residual or Metastatic Osteosarcoma in a Murine Model?

Granero‐Moltó, F. (2015) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-015-4423-6

Nanostructured Selenium for Biomedical Applications:from Theory to Practice

Tran, P. A. (2010) · doi:10.7301/z03t9ffw

Molecular Pathology of Bone and Soft Tissue Tumors

Ordóñez, J. L., Osuna, D., Madoz‐Gúrpide, J., & de Álava, E. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_34

Purinergic signalling in osteosarcoma

Tattersall, L. (2019) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)

Studies on relationships between malignant behaviors and ezrin activity in tissues of canine osteosarcoma patients and a xenograft nude mouse model

Jaroensong, T. (2011) · Institutional Repositories DataBase (IRDB) · doi:10.15083/00005502

Metastasis

Bánfalvi, G. (2013) · Springer eBooks · doi:10.1007/978-94-007-7335-6_5

Tissue-engineering humanised bone sarcoma models in rodents-a preclinical study platform for orthopaedic research

Lahr, C. A. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.207759

Hematopoietic Cell Transplantation for Other Pediatric Solid Tumors

Hayashi, M., Loeb, D. M., & Chen, A. R. (2015) · doi:10.1002/9781118416426.ch64

Tumor characterization using the backscatter coefficient at low and high-frequency

Malinet, C., Mansilla, C., Fajnorovà, I., Rohfritsch, A., Melodelima, D., Dutour, A., & Muleki-Seya, P. (2024) · IEEE Ultrasonics, Ferroelectrics, and Frequency Control Joint Symposium (UFFC-JS) · doi:10.1109/uffc-js60046.2024.10793991

Pre-clinical Murine Models of Bone Sarcomas

Muñoz-García, J., Vargas-Franco, J. W., Grigoriadis, A. E., Lézot, F., & Heymann, D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4306-8_20

An orthotopic model of human osteosarcoma using two isogenic cell lines differing in their ability to form spontaneous pulmonary metastasis

Comstock, K. E., Hall, C. L., Baker, L., & Keller, E. T. (2007) · Cancer Research

Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials

Chen, X., Yang, T.-T., Wang, W., Sun, H., Ma, B., Li, C., Ma, Q., Yu, Z., & Fan, Q. (2009) · Cytotechnology · doi:10.1007/s10616-009-9239-3 · Cited by 37

An Orthotopic Model of Human Osteosarcoma Growth and Spontaneous Pulmonary Metastasis

Luu, H. H., Kang, Q., Park, J. K., Si, W., Luo, Q., Jiang, W., Yin, H. X., MONTAG, A. G., Simon, M. A., Peabody, T. D., et al. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-0365-9 · Cited by 237

Metastasis-associated differences in gene expression in a murine model of osteosarcoma.

Khanna, C., Khan, J. I., Nguyen, P., Prehn, J., Caylor, J., Yeung, C. L., Trepel, J. B., Meltzer, P. S., & Helman, L. J. (2001) · PubMed · Cited by 282

Screening of human osteosarcoma cell line with spontaneous highly pulmonary metastasis in nude mice by orthotopic transplantation and studies on its biological characteristics

Zhang, D. (2000)